Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-25

Clinical Trial Update: Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating prucalopride for dysphagia and ineffective esophageal motility has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: University of Calgary | Conditions: Ineffective Esophageal Motility, Dysphagia | Phase 2 | Status: COMPLETED